Cargando…

Casirivimab/imdevimab: Various toxicities: 2 case reports

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023687/
http://dx.doi.org/10.1007/s40278-022-13677-y
_version_ 1784690397313761280
collection PubMed
description
format Online
Article
Text
id pubmed-9023687
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-90236872022-04-22 Casirivimab/imdevimab: Various toxicities: 2 case reports Reactions Weekly Case Report Springer International Publishing 2022-04-23 2022 /pmc/articles/PMC9023687/ http://dx.doi.org/10.1007/s40278-022-13677-y Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Casirivimab/imdevimab: Various toxicities: 2 case reports
title Casirivimab/imdevimab: Various toxicities: 2 case reports
title_full Casirivimab/imdevimab: Various toxicities: 2 case reports
title_fullStr Casirivimab/imdevimab: Various toxicities: 2 case reports
title_full_unstemmed Casirivimab/imdevimab: Various toxicities: 2 case reports
title_short Casirivimab/imdevimab: Various toxicities: 2 case reports
title_sort casirivimab/imdevimab: various toxicities: 2 case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023687/
http://dx.doi.org/10.1007/s40278-022-13677-y